Back to discover
Drug

Gadolinium

In clinical development
Emerging researchLate-stage developmentRising momentum

Also known as Gd, gadolinio.

3
Research papers
5
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

PET/MR, PET/CT and Whole Body MR in Newly Diagnosed Acute Myeloid Leukemia (AML)

Clinical trial2026-04-17Results expected Q3 2027 · ClinicalTrials.gov

Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection

Clinical trial2026-01-29Results expected Q2 2027 · ClinicalTrials.gov

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Research2008-02-01The New England journal of medicine

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Gadolinium
Aliases & brands
Gdgadolinio
RxNorm CUI
1310171
ChEMBL ID
CHEMBL1232993
UNII
AU0V1LM3JT

Clinical trials

25 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
25
registered trials across all phases
LATEST COMPLETION 2026
5
Active studies
5
Recruiting
9
Late-stage (III+)
11
Completed
9
Discontinued
PHASE DISTRIBUTIONn = 25
Early Phase 12Phase 16Phase 1 / 24Phase 24Phase 2 / 31Phase 44Phase N / A4

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

3 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20082023
Major research themes2
Myocarditis1Sarcoidosis1
Journals, researchers & institutions
Top journals
  • International journal of cardiology1
  • JAMA cardiology1
  • The New England journal of medicine1
Leading researchers
  • Agarwal S1
  • Antel J1
  • Arendt C1
  • Arnold DL1
  • Bar-Or A1
  • Bergh N1
  • Björkenstam M1
  • Bobbio E1
Leading institutions
free-text, unnormalised
  • Department of Clinical Pathology1
  • Department of Clinical Physiology1
  • Department of Hospital Therapy No. 11
  • Goethe University Hospital Frankfurt1
  • Institute for Cardiac Diagnostic and Therapy1
  • Institute for Experimental and Translational Cardiovascular Imaging1

Related diseases

1 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Active research areas
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials